Sale!

MYEOVIgH MM Test Cost

Original price was: 1,400 د.إ.Current price is: 1,050 د.إ.

-25%

The “MYEOVIgH MM Test” is a specialized diagnostic procedure designed to provide comprehensive insights into specific health concerns, particularly targeting the evaluation of genetic markers associated with multiple myeloma, a type of blood cancer. Conducted at DNA Labs UAE, a leading facility renowned for its advanced genetic testing services, this test plays a crucial role in the early detection and management of multiple myeloma by analyzing the patient’s genetic material for any anomalies or predispositions.

Priced at 1050 AED, the MYEOVIgH MM Test is accessible for individuals seeking an in-depth analysis of their genetic risk factors for multiple myeloma. The cost reflects the sophisticated technology and expertise required to accurately identify and interpret the genetic variations that could influence the development of this condition. By opting for this test at DNA Labs UAE, patients can benefit from the lab’s state-of-the-art infrastructure and the professional guidance of genetic counselors, ensuring a comprehensive and reliable assessment of their genetic health concerning multiple myeloma.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYEOVIgH MM Test Cost AED:1050.0 | DNA Labs UAE

Are you concerned about multiple myeloma (MM)? DNA Labs UAE offers the MYEOVIgH MM Test at an affordable cost of 1050.0 AED. This genetic test can help in the diagnosis and prognosis of MM, a type of cancer that affects plasma cells in the bone marrow.

Test Details

The MYEOVIgH MM Test is a genetic test that detects the MYEOV/IgH translocation, a genetic abnormality associated with multiple myeloma. The MYEOV gene on chromosome 11q13 fuses with the IgH gene on chromosome 14, leading to the overexpression of MYEOV and uncontrolled cell growth. This translocation is considered a poor prognostic factor in MM.

Components

  • Sodium Heparin Vacutainer (2ml)

Price

The cost of the MYEOVIgH MM Test is 1050.0 AED.

Sample Condition

The test can be performed on bone marrow or peripheral blood samples.

Report Delivery

Once the sample is received, the report will be delivered within 3-4 days.

Method

The MYEOVIgH MM Test is performed using the FISH (Fluorescence In Situ Hybridization) method.

Test Type

The MYEOVIgH MM Test falls under the category of Genetics.

Doctor

Consult with an oncology doctor for this test.

Test Department

This test is available in the DNA Labs UAE’s Test Department.

Pre Test Information

A Doctors prescription is required for the MYEOVIgH MM Test. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

It is crucial to detect the MYEOV/IgH translocation as it can help guide treatment decisions and prognosis in patients with multiple myeloma. Early detection of this genetic abnormality is vital for better treatment outcomes and managing the disease effectively.

At DNA Labs UAE, we provide accurate and reliable genetic testing services. Consult with our oncology doctor to understand more about the MYEOVIgH MM Test and its implications in multiple myeloma.

Test Name MYEOVIgH MM Test
Components Sodium Heparin Vacutainer (2ml)
Price 1050.0 AED
Sample Condition Bone Marrow \/ Peripheral blood
Report Delivery 3-4 days
Method FISH
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information MYEOV/IgH (MM) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

MYEOV/IgH (MM) is a genetic abnormality that is associated with multiple myeloma (MM), a type of cancer that affects plasma cells in the bone marrow. MYEOV is a gene located on chromosome 11q13 that codes for a protein involved in cell growth and division. IgH refers to the immunoglobulin heavy chain gene, which is frequently rearranged in multiple myeloma.

The MYEOV/IgH translocation occurs when a piece of chromosome 11 containing the MYEOV gene fuses with the IgH gene on chromosome 14. This fusion results in the overexpression of MYEOV, leading to uncontrolled cell growth and the development of multiple myeloma.

The MYEOV/IgH translocation is considered a poor prognostic factor in multiple myeloma, as it is associated with more aggressive disease and poorer treatment outcomes. Detection of this translocation can help guide treatment decisions and prognosis in patients with multiple myeloma.